Expanding Application for Cell & Gene Therapies & Growing Demand for CAR T- Cell Therapies

DublinAnd February 1, 2022 /PRNewswire/ – “Cell and Gene Therapy Market – Global Outlook 2022-2027” report has been added to ResearchAndMarkets.com Show.

The market size of cell and gene therapy has been estimated 4.99 billion US dollars In 2021 it is expected to arrive 36.92 billion US dollars By 2027, at a compound annual growth rate of 39.62% over the forecast period

In the field of cell and gene therapy, gene therapy has gathered pace that has been going on for two decades due to the discovery of many genes responsible for mutations in various diseases. Advances in cell therapy, genetics, and innovative technologies are giving rise to a new era of biological therapies. Also, PRIME designation and marketing authorization for products provide a new opportunity for manufacturer financing and revenue generation.

the main points

According to the American Society for Cell and Gene Therapy Report in 2021, the increase in the number of cell and gene therapy products, application rate and products in clinical trials is driving the growth of the market.

According to the 2021 Dive Biopharma Report, biotech companies that have been actively involved in regenerative drugs and therapies have reported 14 billion US dollars Funding only in six months of 2021 reported 19.9 billion US dollars for the whole year.

Cellular and Gene Therapy Market Segmentation

The increasing application of gene therapies in disease diagnosis and the rapidly growing new drug applications will provide new market space in the coming years. In 2020 around $2.3 billion Only funding from private companies for gene therapies has been reported. By 2025, the US Food and Drug Administration is expected to approve 10-20 products each year, driving the global cell and gene therapy manufacturing market.

In the 2020 Medicine in Development Report, about 176 products in Cancer Therapies were reported in development actions.

geographical view

North America: High economic situation and high spending on healthcare services drive the cell and gene therapy market in North America. The National Institutes of Health, industries, academia, and hospitals are major contributors to the sponsorship and funding of cell and gene therapy products.

Europe: Increasing funding for cell and gene therapy is driving the continuous growth of the cell and gene therapy market Europe. Around 2.6 billion USD Funding reported on Europe For CGTs in 2020, which increased by 103% compared to previous years. In the cell therapy department, 1.8 billion US dollars And in gene therapy, $2.3 billion Financing in 2020 accounted for 196% and 111% growth respectively

landscape seller

The major players in the cell and gene therapy market are Gilead Sciences, Novartis, Smith Nephew, Amgen, Organogenesis, Roche (Spark Therapeutics), Dendreon, Vericel and Bristol-Myers Squibb Company.

An increasing number of mergers and acquisitions gives new market growth potential. Gilead Sciences acquired Kite Pharma in 2020. Also, Avexis was acquired by Novartis in 2018, and Osiris Therapeutics was acquired by Smith & Nephew.

Key Growth Factors

  • gain integration
  • Expansion of manufacturing plants and technological progress
  • Expanding the scope of application of cellular and genetic therapies
  • Increasing demand for auto T-cell therapies
  • New product approvals and pipeline products increase

major sellers

  • Gilead Sciences
  • Novartis
  • Smith Nephew (Osiris Therapeutic)
  • Amgen
  • Member composition
  • Roche (Spark Remedies)
  • Denderion
  • Verisil
  • Bristol-Myers Squibb

Other Notable Sellers

  • Abeona Therapeutics
  • APAC Biotech Pvt Ltd
  • nillam
  • Louvre
  • Tegu science
  • Avita Medical
  • Angels Company
  • BioSolution Co. Ltd.
  • Chessy Pharmaceuticals
  • CoolPlant
  • CO.DON
  • koristem
  • Bluebird Bio Company
  • biological solution
  • stem research
  • GC . cell
  • Sanofi
  • Biology Gensight
  • Human Stem Cell Institute
  • JW CreaGene Co., Ltd.
  • GCR Pharmaceuticals
  • Japanese Tissue Engineering (J-TEC)
  • colon tissue
  • Medipost
  • Mall Med
  • Nuvasive Inc.
  • Nybro . company
  • Orchard Therapeutics
  • orthocel
  • Pfizer
  • Pharmasil
  • Sibino Genetech
  • Shanghai Sunway Biotechnology
  • RMS Regenerative Medical System
  • Takeda Pharmaceutical Company
  • Teromo

upcoming sellers

  • Biomarin medicines
  • Military Pharmaceuticals
  • Castle Creek Biosciences, Inc
  • libella gene therapies
  • CARsgen treatments
  • Harin Biotechnology Co., Ltd.
  • IUD
  • Krystal Biotech Inc.
  • JW Therapeutic
  • Posida treatments

Main topics covered:

1 Research Methodology

2 Research objectives

3 search process

4 Scope and coverage
4.1 Market Definition
4.2 base year
4.3 Scope of the study

5 Report Assumptions and Caveats
5.1 Key Warnings
5.2 Currency Converter
5.3 Derivation of the market

6 A quick look at the market

7 Introduction
7.1 Overview
7.1.1 Approved Products of Cell and Gene Therapy 2020-2021
7.2 Phase III cell and gene therapy products
7.3 Cell and Gene Therapy Roadmap

8 Market Opportunities and Trends
8.1 Increase in the number of mergers and acquisitions
8.2 Expansion of CGT مصانع plants
8.3 Expanding the range of applications of cellular and genetic therapies
8.4 Increasing demand for T-cell therapies in automobiles

9 Market Growth Factors
9.1 New product approvals and product pipeline increase
9.2 Support for CGT’s Basic Funding and Allocation
9.3 Increased use of CGT products for disease care
9.4 Increased use of CGT products to treat diseases

10 Market Restrictions
10.1 The high cost of cellular and genetic therapies
10.2 Ethical issues related to genetic material
10.3 Strict Regulations for CGT Approvals

11 market view
11.1 Market Overview
11.2 Market Size and Forecast
11.3 Five Forces Analysis

12 treatment
12.1 Market Capture and Growth Engine
12.2 Market Overview
12.3 Gene therapy
12.4 Cell Therapy

13 app
13.1 Market Capture and Growth Engine
13.2 Market Overview
13.3 Oncology
13.4 Genetic disorders
13.5 Dermatology
13.6 Diseases of the musculoskeletal system
13.7 Other diseases

14 end user
14.1 Market Snapshot and Growth Engine
14.2 Market Overview
14.3 Hospitals
14.4 Cancer Care Centers
14.5 Wound care centers
14.6 Other Users

15 Geography
15.1 Market Capture and Growth Engine
15.2 Geographical overview
15.2.1 Global Cell and Gene Therapy Market by Geography

For more information on this report, visit https://www.researchandmarkets.com/r/z7gm5

Media contact:

Research and Markets
Laura Wooddirector, mentor
[email protected]

For EST office hours, call +1-917-300-0470
For US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900

US Fax: 607-646-1904
Fax (outside the US): +353-1-481-1716

SOURCE Research & Markets


Leave a Comment